Stay updated with breaking news from Nasdaq Alt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Connective Portfolio Management LLC bought a new stake in Altimmune, Inc. (NASDAQ:ALT – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 16,000 shares of the company’s stock, valued at approximately $180,000. Other hedge funds and other institutional investors also recently […]
GSA Capital Partners LLP raised its stake in Altimmune, Inc. (NASDAQ:ALT – Free Report) by 153.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 445,868 shares of the company’s stock after purchasing an additional 269,676 shares during the quarter. GSA Capital […]
B. Riley reissued their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research note released on Tuesday morning, Benzinga reports. They currently have a $20.00 target price on the stock. A number of other brokerages have also weighed in on ALT. The Goldman Sachs Group started coverage on shares of Altimmune […]
WealthPlan Investment Management LLC purchased a new position in Altimmune, Inc. (NASDAQ:ALT – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 11,931 shares of the company’s stock, valued at approximately $31,000. A number of other institutional investors and hedge funds also […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) was up 5.8% during trading on Tuesday . The company traded as high as $10.06 and last traded at $9.93. Approximately 926,426 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 6,349,605 shares. The stock had previously closed at $9.39. Wall […]